Asphalion’s Board of Directors is pleased to announce the appointment of Christopher Mann as new Scientific and Regulatory Affairs Director.
Read moreThis is the Phase I clinical trial of the cell therapy drug HC016 developed by Histocell, which is being carried out at the Hospital de Cruces (Bilbao), in Spain. The objective of this trial is to off...
Read morePall Corporation expands production capacity in the United States and Europe to support industry demand
Read moreAlmirall, a global biopharmaceutical company based in Barcelona, and Tyris Therapeutics, a next generation gene therapy company founded by Columbus Venture Partners, have announced a strategic ...
Read moreLa distrofia muscular de Duchenne es una enfermedad minoritaria hereditaria ligada al cromosoma X, que se manifiesta mayoritariamente en varones y que causa debilidad progresiva, pérdida de la marcha...
Read moreUn equipo de investigadores del IRTA, en colaboración con la empresa Selección Batallé, ha estudiado el determinismo genético y las regiones genómicas asociadas con la inmunocompetencia global y ...
Read morePatients with severe COVID-19 disease have significantly shorter telomeres, according to a study conducted by researchers at the Spanish National Cancer Research Centre (CNIO) in collaboration with th...
Read moreInvestigadores de la Universidad de Cambridge, la Universidad de Pittsburgh y el Instituto de la Visión de Paris han tratado con éxito una ceguera de origen genético y han encontrado que, inesperad...
Read moreSplice Bio, a gene therapy company based on technology developed in the Muir Lab at Princeton University, announced today that it has appointed JeanPhilippe Combal as Chairman of its Board of Director...
Read moreAs chemical and life science companies seeking to monetize their IP portfolios emerge from the challenges of COVID-19, 2021 looks to be a year that will see increased product licensing, acquisitions a...
Read moreLa Academia CIBERER para Pacientes organizó una serie de 3 seminarios en línea sobre diagnóstico, terapias e investigación sobre sorderas el pasado mes de noviembre. Estos seminarios están dispon...
Read moreEn un estudio con la participación del Hospital Clínic-IDIBAPS, del ICEMEQ y la Sección de Cirugía Maxilofacial, se demostró por primera vez que la pérdida de función de FAT1 promueve las carac...
Read more